▲ Peaking
Business
All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy shows promise in slowing cognitive decline for early Alzheimer's patients.
Biogen
Coverage by Biogen as tracked by Newsylist.
1trends covered
0broke first
1articles tracked